List of Tables

Table 1. Primary Hyperoxaluria Treatment Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Primary Hyperoxaluria Treatment Market Restraints

Table 3. Primary Hyperoxaluria Treatment Market Trends

Table 4. Primary Hyperoxaluria Treatment Industry Policy

Table 5. Global Primary Hyperoxaluria Treatment Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Primary Hyperoxaluria Treatment Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Primary Hyperoxaluria Treatment Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Primary Hyperoxaluria Treatment Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Primary Hyperoxaluria Treatment Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Primary Hyperoxaluria Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Primary Hyperoxaluria Treatment Mergers & Acquisitions, Expansion Plans

Table 12. Global Primary Hyperoxaluria Treatment Manufacturers Product Type

Table 13. Head Office and Primary Hyperoxaluria Treatment Production Site of Key Manufacturer

Table 14. Primary Hyperoxaluria Treatment Capacity of Major Manufacturers and Future Plan

Table 15. China Primary Hyperoxaluria Treatment Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Primary Hyperoxaluria Treatment Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Primary Hyperoxaluria Treatment Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Primary Hyperoxaluria Treatment Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Primary Hyperoxaluria Treatment Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Primary Hyperoxaluria Treatment Production by Region, 2020-2025, (K Units)

Table 21. Global Primary Hyperoxaluria Treatment Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Primary Hyperoxaluria Treatment Upstream (Raw Materials)

Table 23. Global Primary Hyperoxaluria Treatment Typical Customers

Table 24. Primary Hyperoxaluria Treatment Typical Distributors

Table 25. by Type, Global Primary Hyperoxaluria Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Primary Hyperoxaluria Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Primary Hyperoxaluria Treatment Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Primary Hyperoxaluria Treatment Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Primary Hyperoxaluria Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Primary Hyperoxaluria Treatment Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Primary Hyperoxaluria Treatment Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2020-2031

Table 35. Oxthera Company Information, Head Office, Market Area, and Industry Position

Table 36. Oxthera Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 37. Oxthera Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Oxthera Company Profile and Main Business

Table 39. Oxthera Recent Developments

Table 40. Dicerna Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 41. Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 42. Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Dicerna Pharmaceuticals Company Profile and Main Business

Table 44. Dicerna Pharmaceuticals Recent Developments

Table 45. Allena Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Allena Pharmaceuticals Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 47. Allena Pharmaceuticals Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Allena Pharmaceuticals Company Profile and Main Business

Table 49. Allena Pharmaceuticals Recent Developments

Table 50. Biocodex Company Information, Head Office, Market Area, and Industry Position

Table 51. Biocodex Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 52. Biocodex Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Biocodex Company Profile and Main Business

Table 54. Biocodex Recent Developments

Table 55. Alnylam Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 56. Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 57. Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Alnylam Pharmaceuticals Company Profile and Main Business

Table 59. Alnylam Pharmaceuticals Recent Developments

Table 60. Tecoland Corporation Company Information, Head Office, Market Area, and Industry Position

Table 61. Tecoland Corporation Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 62. Tecoland Corporation Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Tecoland Corporation Company Profile and Main Business

Table 64. Tecoland Corporation Recent Developments

Table 65. Zhejiang Tianxin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 66. Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 67. Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Zhejiang Tianxin Pharmaceutical Company Profile and Main Business

Table 69. Zhejiang Tianxin Pharmaceutical Recent Developments

Table 70. Takeda Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 71. Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 72. Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Takeda Pharmaceuticals Company Profile and Main Business

Table 74. Takeda Pharmaceuticals Recent Developments

Table 75. Wuxi Further Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 76. Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Models, Specifications, and Application

Table 77. Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Wuxi Further Pharmaceutical Company Profile and Main Business

Table 79. Wuxi Further Pharmaceutical Recent Developments

List of Figures

Figure 1. Primary Hyperoxaluria Treatment Picture

Figure 2. Global Primary Hyperoxaluria Treatment Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Primary Hyperoxaluria Treatment Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Primary Hyperoxaluria Treatment Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Primary Hyperoxaluria Treatment Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Primary Hyperoxaluria Treatment Sales Quantity (K Units) & (2020-2031)

Figure 7. China Primary Hyperoxaluria Treatment Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Primary Hyperoxaluria Treatment Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Primary Hyperoxaluria Treatment Market Share of Global, 2020-2031

Figure 10. Global Primary Hyperoxaluria Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Primary Hyperoxaluria Treatment Key Participants, Market Share, 2024

Figure 12. Global Primary Hyperoxaluria Treatment Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Primary Hyperoxaluria Treatment Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Primary Hyperoxaluria Treatment Production Market Share & Forecast by Region, 2020-2031

Figure 15. Primary Hyperoxaluria Treatment Industry Chain

Figure 16. Primary Hyperoxaluria Treatment Procurement Model

Figure 17. Primary Hyperoxaluria Treatment Sales Model

Figure 18. Primary Hyperoxaluria Treatment Sales Channels, Direct Sales, and Distribution

Figure 19. Oral

Figure 20. Intravenous

Figure 21. Others

Figure 22. by Type, Global Primary Hyperoxaluria Treatment Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Primary Hyperoxaluria Treatment Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 25. by Type, Global Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Primary Hyperoxaluria Treatment Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 27. Type 1

Figure 28. Type 2

Figure 29. Type 3

Figure 30. by Application, Global Primary Hyperoxaluria Treatment Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Primary Hyperoxaluria Treatment Revenue Market Share, 2020-2031

Figure 32. by Application, Global Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 33. by Application, Global Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Primary Hyperoxaluria Treatment Price, 2020-2031, (US$/Unit)

Figure 35. By Region, Global Primary Hyperoxaluria Treatment Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2020-2031

Figure 37. North America Primary Hyperoxaluria Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Primary Hyperoxaluria Treatment Consumption Value Market Share, 2024

Figure 39. Europe Primary Hyperoxaluria Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Primary Hyperoxaluria Treatment Consumption Value Market Share, 2024

Figure 41. Asia Pacific Primary Hyperoxaluria Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Primary Hyperoxaluria Treatment Consumption Value Market Share, 2024

Figure 43. South America Primary Hyperoxaluria Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Primary Hyperoxaluria Treatment Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Primary Hyperoxaluria Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 47. by Type, United States Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 50. by Type, Europe Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 53. by Type, China Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 56. by Type, Japan Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 59. by Type, South Korea Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 62. by Type, Southeast Asia Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 65. by Type, India Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Primary Hyperoxaluria Treatment Sales Quantity, 2020-2031, (K Units)

Figure 68. by Type, Middle East & Africa Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Primary Hyperoxaluria Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches